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Background and aims: Physical activity and nutritional supplementation interventions may be used to
ameliorate age-related loss of skeletal muscle mass and function. Previous reviews have demonstrated
the beneﬁcial effects of resistance exercise training (RET) combined with protein or essential amino acids
(EAA) in younger populations. Whether or not older adults also beneﬁt is unclear. The aim of this review
was to determine whether regular dietary supplementation with protein/EAA during a RET regimen
augments the effects of RET on skeletal muscle in older adults.
Methods: A literature search was conducted in August 2015 using MEDLINE, EMBASE, SPORTDiscus, and
CINAHL Plus to identify all controlled trials using a RET regimen with and without protein/EAA sup-
plementation. Outcome variables included muscle strength, muscle size, functional ability, and body
composition.
Results: Fifteen studies fulﬁlled the eligibility criteria, including 917 participants with a mean age of
77.4 years. Studies involving both healthy participants and those described as frail or sarcopenic were
included. Overall, results indicated that protein supplementation did not signiﬁcantly augment the ef-
fects of RET on any of the speciﬁed outcomes. Exceptions included some measures of muscle strength
(3 studies) and body composition (2 studies). Meta-analyses were conducted but were limited because of
methodologic differences between studies, and results were inconclusive.
Conclusions: Systematic review and meta-analysis of controlled trials reveal that protein/EAA supple-
mentation does not signiﬁcantly augment the effects of progressive RET in older adults.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Sarcopenia is deﬁned as an age-related loss of muscle mass and
function, and is associated with frailty and reduced functional ability
and independence,1e3 as well as increased incidence of falls, disability,
infection, and mortality.1,4e7 Combined with the growing economic
impact, demonstrated by US healthcare costs from 2000 which attri-
bute $18.5 billion to sarcopenia and associated health problems,8
sarcopenia is a serious public health issue. Interventions to maintain
muscle mass in older adults are a major priority and would bee analysis; BIS; bioelectrical
CT, computed tomography;
al amino acids; FFM, fat free
sue mass; MM, muscle mass;
rformance Oriented Mobility
stematic Reviews and Meta-
resistance exercise training;
and Long-Term Care Medicine. Thexpected to result in both improved quality of life in old age and
decreased healthcare costs.
Although the design of effective interventions has been a major
goal for 30 years, so far only resistance exercise has shown any real
beneﬁt in improving muscle mass in older people. In younger adults,
resistance exercise has been shown to acutely sensitize skeletal
muscle to the anabolic effects of ingested protein or essential amino
acids (EAA).9,10 Hence, when considered in terms of a chronicDanielle Thomas is funded by the MRC Arthritis Research UK Center for
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supplementation (protein, EAA, or leucine) have an additive effect on
muscle strength and fat free mass (FFM).11 One might assume,
therefore, that an intervention combining RET and supplementation
could be an effective strategy against sarcopenia in older adults,
however, the presence of an effect in younger adults does not neces-
sarily mean there will be an effect in older adults. The acute anabolic
responsiveness to both resistance exercise and protein supplemen-
tation is blunted in older adults compared with younger adults,12,13
and this is thought to translate into a chronic blunting of respon-
siveness.14 Thus, it is plausible that the chronic response to a combi-
nation of these factors may also differ in older adults.
In spite of this anabolic blunting, previous reviews of studies in
older adults have found chronic additive effects of RET and protein/
EAA supplementation compared with RET only, in terms of FFM11,15
and muscle strength.11 However, there are issues with the relatively
lowminimum age limit inclusion criteria for these reviews; one used a
cut-off of 50 years of age for the “older” age group, and the oldest
participant included was 72 years of age, and in the other the lower
age limit was an average of 60 years of age and included studies in
which some participants were as young as 50 years of age. These age
categories are not necessarily representative of older adults, and a cut-
off mean 70 years of age may be more appropriate to deﬁne “elderly.”
Longitudinal evidence shows that muscle strength and power
continue to decline into advanced older age,16 and a dramatic increase
in the prevalence of sarcopenia has been observed in the eighth
decade of life.5 Hence, it would appear that the muscle of people aged
over 70 years is performing differently to that of those aged 50 or
60 years, meaning it is likely that the responsiveness to anabolic fac-
tors may also differ between these age ranges. This would mean that
the inclusion of studies involving these relatively younger participants
may mask any differences in the effects of the combined intervention
on the truly older adults. The use of an older cut-off point to deﬁne
older adults is supported by the studies demonstrating anabolic
resistance,12,13 both of which reported an average age of 70 years, and
is likely to give a better representation of the effect of anabolic
resistance on chronic responsiveness to RET and protein supplemen-
tation. Furthermore, arguably the most important outcomes in terms
of a practical impact of an intervention are those related to functional
ability. Such outcomes are highly relevant to quality of life and the
maintenance of an independent lifestyle, which are key priorities
when setting lifestyle recommendations. To date, the combined ef-
fects of RET and protein supplementation on functional ability have
yet to be addressed within a systematic review.
The aim of this systematic review was to determine whether
protein or EAA supplementation can augment the effects of RET in
older adults (ie, studies with an average age of 70 years or older).
These effects included changes from baseline inmuscle strength as the
primary outcome, and secondary outcomes of muscle size, body
composition, and indicators of functional ability, where functional
ability was deﬁned as the ability to perform everyday tasks and ac-
tivities important for the maintenance of physical independence.
Methods
The systematic review was conducted in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) report.17 Although this protocol has not been previously
published, all procedures were determined in advance.
Selection Criteria
Inclusion criteria were (1) controlled trials in humans imple-
menting a progressive RET regimen in combination with a protein or
EAA supplement, and inclusion of a comparison group combining RETwith either a placebo/non-protein supplement or no supplement at all
[Studies comparing higher versus lower protein diets were accepted
providing the low protein diet was equivalent to the US recommended
daily allowance (RDA) for protein (0.8 g$kg1$day1)]18; (2) studies
including participants with a mean age of 70 years or over, both
healthy and frail; (3) studies within any publication category and all
languages; and (4) outcome measures including muscle strength
(primary), muscle size, functional ability (deﬁned as the ability to
perform everyday tasks and activities important for the maintenance
of physical independence), and body composition (secondary).
Studies were excluded if the intervention was administered with
an agent previously shown to result in muscle gains (with the
exception of vitamins and minerals), or if it was administered to a
speciﬁc patient group or with the intention of treating a clinical
condition other than frailty or sarcopenia.
Information Sources and Search
An electronic search of online databases was conducted in August
2015, using selected key words, “free text” terms, indexed terms, and
Boolean operators (Table 1). Search strategies were constructed using
search terms to identify papers on elderly populations with suitable
supplementation and training regimens and a search ﬁlter to limit
retrievals to studies in humans. The search strategies were applied to
MEDLINE (1946 to August 2015); EMBASE (1980 to August 2015);
CINAHL Plus (1937 to August 2015); SPORTDiscus (1949 to August
2015). Recursive searching of the bibliographies of eligible studies and
relevant reviews was performed to identify additional studies.
Study Selection
Titles and abstracts were screened for relevance by 1 reviewer
(D.T.). Clearly irrelevant titles were removed. Full-text papers were
obtained for potentially relevant studies, via a combination of online
databases and direct contact with the authors, and these were further
evaluated to determine whether they met the inclusion criteria. Two
reviewers (D.T. and C.G.) independently assessed full-texts for eligi-
bility, with a third reviewer (D.S.) moderating if necessary. Studies
deemed eligible were included in the systematic review.
Data Extraction
Data were extracted from each of the included papers using a
standardized data extraction form. Details of interest included various
aspects of study design, resistance training regimens, protein/EAA
supplements, and the comparison treatment, as well as participant
characteristics and baseline protein intake. Data were sought for
outcomes of muscle strength, muscle size, functional ability, and body
composition. Where necessary, the required data were interpolated
from ﬁgures or calculated from the reported data. Corresponding
authors were contacted if this information could not be obtained from
the paper, and if data could not be obtained, the study (or outcome
measure) was excluded from meta-analysis.
Quality Assessment
Methodologic quality of included studies was assessed using the
Physiotherapy Evidence Database (PEDro) scale.19 A score of 6 or
higher indicated moderate to high quality.
Summary Measures and Synthesis of Results
Extracted data were collated and a review was conducted for the
primary outcome (ie, muscle strength, as well as the secondary out-
comes of muscle size, functional ability and body composition). This
Table 1
Example Search Strategy*
1 Aged/or “aged, 80 and over”/ or frail elderly/
2 Aging/ or longevity/
3 (old* adj (adult* or age* or people or person* or population*)).tw.
4 (elder* or old* or ?enarian or aged or ag?ing or senior* or geriatric* or
frail).mp.
5 1 or 2 or 3 or 4
6 Muscles/or muscle, skeletal/
7 Exp Muscle Strength/
8 Muscle Weakness/
9 Muscular atrophy/ or sarcopenia/
10 (musc* adj2 (mass or strength or size or cross sectional area or CSA or
thick* or power or growth or enlarge* or area or volume or
hypertrophy)).tw.
11 Muscle Development/
12 Exercise therapy/ or resistance training/
13 (weigh* OR streng* OR resis*) adj2 (train* OR exerc* OR therap*).mp.
14 Hypertrophy/
15 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14
16 Exp Dietary Supplements/
17 Food, Fortiﬁed/
18 ((protein* OR amino acid*) adj3 supplement*).tw.
19 Proteins/
20 Exp Amino Acids/
21 Exp Dietary Proteins/
22 16 or 17 or 18 or 19 or 20 or 21
23 5 and 15 and 22
24 Exp animals/ not humans.sh
25 23 not 24
CSA, cross-sectional area.
*Ovid MEDLINE (R) search, adapted for other databases.
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Meta-analysis was conducted on comparable outcomes reported in
a minimum of 2 studies. Similar study protocols were a requisite for
comparison using meta-analysis, and, despite all included studies
addressing the questioned posed by this review, fundamental differ-
ences in their protocols meant that a number of study combinations
were unsuitable for meta-analysis. Key criteria for determining study
comparability included additional supplementation with vitamin D
(which may also inﬂuence muscle related outcomes20), the frequency
of protein supplementation (ie, daily or only on training days), the
timing of supplementation (including number of doses), and
the amount of protein supplemented, with consideration also given to
the type of protein supplemented and the duration of the study.
Results
Study Selection
A total of 11,770 publications were identiﬁed by the literature
search, of which 16 publications including 15 studies met all of the
inclusion criteria and were included in the systematic review21e36
(Figure 1). Two publications24,27 reported results from the Frail
Older People-Activity and Nutrition Study in Umeå and, therefore,
were considered here as 1 study.24
Study Characteristics
The 15 eligible studies included 917 participants with a mean age
of 77.4 years (range 60e100 years) (Table 2). Six studies including 400
participants were conducted in older adults described as frail, sarco-
penic, or mobility limited.21,24,26,28,29,31 Individuals in the remaining
9 studies were categorized as healthy.22,23,25,30,32e36 Three studies
included only male populations,22,25,35 2 included female only
populations,28,33 and the remaining 10 were mixedpopulations.21,23,24,26,29e32,34,36 Of the total participants, 32% were
male and 68% were female. All studies were published in English.
Resistance exercise regimens varied in frequency from 2 to 5 oc-
casions per week, with a mean (SD) of 3 (1) per week. Programs lasted
between 7 weeks and 1 year, with a mean (SD) of 18 (11) weeks. All
studies reported a progressive exercise regimen; 9 comprised both
upper and lower limb training,25,30e37 and 6 involved training of the
lower limbs alone.23,24,26e28,38 In addition to resistance exercise, par-
ticipants of 5 studies26,28,30,35,38 undertook co-interventions including
functional and/or balance exercises (Table 2).
A total of 10 studies included daily protein sup-
plementation,21e23,28,29,31,32,34e36 1 included supplementation on
6 days per week,33 and in the remaining 4, participants received
supplements only on the day of training.24e26,30 Baseline daily protein
intake was reported in 8 studies22,25,29e33,36 (Table 2), giving a mean
(SD) of 1.08 (0.07) g$kg1$d1 (range 0.97e1.24 g$kg1$d1). The
amount of protein supplemented varied from 6 g per day to 45 g per
day with a mean (SD) of 19 (11) g (Table 2). Eight supplemented
groups24,25,29e32,34,35 received protein derived from milk (casein,
whey, chocolate milk), 1 group received soy-based protein,21 1 group
was supplementedwith lean redmeat,33 2 studies did not disclose the
nature of the protein supplement,23,26 2 groups received EAA,22,28 and
1 group received only leucine.36 Timing of ingestion was inconsistent;
in 3 studies, the supplement was administered immediately after
training22,24,30; in 1 study administration was immediately before
training26; in 1 study one-half of the supplement was administered
before training and half after25; 8 studies administered supplements
at a consistent time relative to meals21,23,28,29,31e33,36; the 2 remaining
studies used a combination of supplementation after meals and after
training.34,35 In addition to protein, 6 studies also supplemented
participants with vitamin D,21,23,26,33e35 with reported doses ranging
from 2 to 25 mg and 2 doses given as approximate proportions of
recommendations.
The studies were highly variable in terms of both study charac-
teristics and outcome measures, and as a consequence, only 2 studies
were sufﬁciently similar to be included in a meta-analysis. The results
were, thus, inconclusive and are not reported here, although forest
plots are available in Supplementary File 1.Study Quality
The median overall quality score derived using the Physiotherapy
Evidence Database scale was 7/10 (range 4e10), and the median
score for internal validity was 5/8 (range 2e8) (Table 3). All studies
scored 2/2 for statistical reporting.Effect of Intervention on Muscle Strength
All 15 studies included in the systematic review included a
measurement of muscle strength, although a number of different
muscle groups were studied (Table 4). Eleven out of 15 studies
demonstrated signiﬁcant improvements from baseline in every
measure of muscle strength in all groups undertaking RET with
protein/EAA supplementation. Of the remaining studies, 1 demon-
strated signiﬁcant improvements in 6 of the 8 strength measure-
ments included,26 2 reported signiﬁcant increases in all
measurements except handgrip strength,29,32 and 1 measured only
handgrip strength and reported no change.34 Three of the 15 studies
reported signiﬁcant differences between control and supplemented
groups, with greater improvements in the supplemented groups in
measures of knee extension strength28,33 and hand grip strength,23
and 1 study reported a trend for greater improvement in leg ﬂexion
strength.36
Fig. 1. Flow of studies through the review process.
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Muscle size
Eight studies investigated the effect of supplementation on muscle
size (Table 4). Six studies measured thigh muscle cross-sectional area
using computed tomography, another measured midarm, calf, and hip
circumference, and the other measured midupper arm muscle area,
triceps skinfold, and calf circumference. All but 1 of the studies which
used computed tomography to measure cross-sectional area reported
signiﬁcant increases in both supplemented and nonsupplement
groups, however, there were no signiﬁcant differences between the
groups. No changes were reported in any other measure of muscle
size.
Functional ability
At least 1 functional ability outcome was assessed in 12 out of the
15 included studies, with 27 outcomes assessed in total (Table 4).
There was much heterogeneity among outcome measures, which
included chair rise ability (6 studies), gait velocity (5 studies), walking
capacity (4 studies), the Timed Up and Go (TUG) test (3 studies),
balance tests (2 studies), stair climb speed (1 study), and the 4-square
step test (1 study). Three studies included a “composite” of some of
these physical performance indicators; 2 used the Short PhysicalPerformance Battery (SPPB) which combines balance, gait speed, and
chair rise ability,37 and 1 used Tinetti’s Performance Oriented Mobility
Assessment (POMA) test combining balance and gait.38 Of the 27
functional ability measurements, 21 were signiﬁcantly improved after
the intervention period, although none of these improvements were
signiﬁcantly different with protein/EAA supplementation compared
with nonsupplemented controls.
Body composition
Body composition was assessed in 9 studies (Table 4). Body
composition was assessed using dual energy X-ray absorptiometry in
all studies except 2; one of which used a segmental multifrequency
bioelectrical impedance analysis technique, and the other used
bioelectrical impedance spectroscopy. Measurements included total
lean body mass (LBM) in 6 studies; total body fat mass (FM) in 6
studies; percentage FM in 3 studies; estimated total muscle mass
(MM) in 2 studies; and FFM in 1 study. A number of studies also
included regional measurements of body composition: leg lean tissue
mass (LTM) in 3 studies; appendicular LTM in 2 studies; estimated
appendicular MM in 1 study; estimated leg MM in 1 study; leg FM and
percentage FM in 1 study; and arm LTM in 1 study. Of the 28 mea-
surements of body composition, 6 demonstrated no signiﬁcant change
during the studies. Improvement in body composition with no
Table 2
Study Characteristics
Participant Details Training Details Protein/EAA and Placebo Supplement Details
Author, Year Number of
Participants
Mean
Age,
Years
Frail/Mobility
Limited/
Sarcopenic
Baseline
Protein
Intake
(g$kg1$day1)*
Study Length
and RT Frequency
Type of RT RT Intensity Functional/
Balance
Training
Type of Protein Frequency
(Daily/With
Training)
Timing of Ingestion Amount Control
Treatment
Fiatarone
et al, 199421
50 86.7 Y NA 3 d/wk  10 wk LL 80% 1-RM N Soy-based Daily Evening 15 g
approx.
Water
Godard
et al, 200222
17 71.5 N 1.14 3 d/wk  12 wk LL 80% 1-RM N EAA (1.86 g L-lysine,
2.24 g L-leucine,
1.40 g L-valine,
1.86 g L-
phenylalanine,
1.76 g L-threonine,
1.30 g L-histidine,
1.2 g L-isoleucine,
0.38 g L-methionine)
Daily After training 12 g Exercise
only
Bunout
et al, 200423
47 74.1 N NA 2 d/wk  1 year LL þ UL Light N Undisclosed protein Daily Between meals 15 g Exercise
only
Rosendahl et al,
200624,y
91 85.2 Y NA 5 d/2 wk  13 wk LL 8e12 RM Y Milk-based With training After training 7.4 g CHO
Verdijk
et al, 200925
28 72.0 N 1.10 3 d/wk  12 wk LL 60%e80% 1-RM N Casein With training 10 g before, 10 g
after training
20 g Water
Zak et al,
200926
40 78.7 Y NA 5 d/wk  7 wk LL 80% 1-RM Y Undisclosed protein With training Before training 12 g
approx.
Water
Kim et al,
201228
77 79.2 Y NA 2 d/wk  3 months LL þ UL Moderate Y EAA (42.0% leucine,
14.0% lysine, 10.5%
valine, 10.5%
isoleucine, 10.5%
threonine, 7.0%
phenylalanine, 5.5%
other)
Daily Twice daily 6 g Exercise
only
Tieland et al,
201229
62 78.5 Y 1.00 2 d/wk  24 wk LL þ UL 50%e75%
1-RM
N Milk-based Daily 15 g after breakfast,
15 g after lunch
30 g CHO
Arnarson et al,
201330
161 73.9 N 1.00 3 d/wk  12 wk LL þ UL 75%e80% 1-RM N Whey With training After training 20 g CHO
Chalé et al,
201331
80 77.7 Y 0.97 3 d/wk  6 months LL þ UL 80% 1-RM N Whey Daily 20 g after breakfast,
20 g after dinner
40 g CHO
Leenders
et al, 201332
60 70.0 N 1.15 3 d/wk  24 wk LL þ UL 60%e80% 1-RM N Milk-based (80% Casein,
20% Whey)
Daily After breakfast 15 g CHO
Daly et al,
201433
100 72.8 N 1.08 2 d/wk  4 months LL þ UL Moderate Y Red meat 6 d/wk Meals, after training 45 gz CHO
Franzke et al,
201534
64 82.7 N NA 2 d/wk  6 months LL þ UL Light to heavy N Whey Daily Morning and after
training
20.7 g Exercise
only
Mitchell
et al, 201535
16 74.4 N NA 3 d/wk  12 wk LL þ UL 75%e85% 1-RM N Chocolate milk Daily After breakfast or
after training
14 g Placebo
drink
Trabal
et al, 201536
24 84.5 N 1.20 3 d/wk  12 wk LL 65% 1-RM Y Leucine Daily 5 g after lunch, 5 g
after dinner
10 g CHO
1-RM, 1-repetition maximum; CHO, carbohydrate; d, days; LL, lower limb; N, no; RT, resistance training; UL, upper limb; wk, weeks; Y, yes.
*NA indicates studies did not report baseline protein intake.
yRosendahl et al 200624 includes Carlsson et al, 2011.27
zApproximately 220 g (raw weight) or 160 g (cooked weight) lean red meat equated to 45 g protein.
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D.K. Thomas et al. / JAMDA 17 (2016) 959.e1e959.e9959.e6difference between treatment groupswas shown in 17measurements,
although within-group analysis of 2 of these measurements within 1
study indicated a signiﬁcant decrease in total FM and body fat per-
centage in the protein supplemented group but not the control
group.33 Five measurements from 2 studies indicated signiﬁcant dif-
ferences between groups,29,33 with greater increases in LBM, leg LTM,
appendicular LTM, and FM in the supplemented groups compared
with the exercise-only controls.
Discussion
This systematic review presents evidence from 15 studies inves-
tigating the additive effects of RET and protein supplementation on
skeletal muscle strength and size, body composition, and functional
ability in older adults. Studies reported overall improvement from
baseline for the majority of outcomes, indicating a positive effect of
RET. However, across the 15 studies, these improvements were not
signiﬁcantly different in groups receiving protein/EAA supplements
and undergoing RET compared with RET alone.
A previous systematic review has shown that older muscle dem-
onstrates an adaptive response to RET across a range of outcomes,39
hence, RET alone is considered an effective strategy for combatting
sarcopenia. Given the anabolic properties of both resistance exercise
and protein/EAA ingestion, it is plausible that the combination of
these factors in a chronic intervention may have an additive effect and
so enhance the responses shown with RET alone. Certainly, this has
been shown to be the case in younger adults,11 however, despite in-
dividual signiﬁcant results in strength and body composition out-
comes, the overall results of the present review indicate that this does
not hold true for older adults.
This overall absence of an additive effect, in contrast to that of
younger adults, may be a result of the mechanisms of anabolic resis-
tance in older muscle. For example, the expression and activation of
proteins responsible for EAA sensing and signaling are reduced in
older people,13 meaning the extent to which the subsequent cascades
can be activated is limited, causing a blunted anabolic response
compared with younger adults. Thus, if the limit for activation has
been reached, any increase in the upstream signal (ie, more amino
acids) will not result in any additional response. Where reported, all
baseline protein intakes were within the RDA, and with lower sensi-
tivity to higher protein intakes, this may have been sufﬁcient to elicit a
maximal protein synthetic response in combination with RET, prior to
any supplementation. Certainly, there is evidence to suggest that there
is no beneﬁt for older adults in consuming more than the RDA for
protein; in a 12-week trial of adults aged 50e80 years, daily protein
intake was increased from 0.9 g$kg1$d1 to 1.3 g$kg1$d1 with no
additional response to RET.40 Furthermore, when the effects of
consuming the RDA were compared with a higher protein dose in
older adults performing RET, the metabolic adaptations to increased
protein intake actually reduced the utilization of protein.41 However,
data from a recent study in older men do indicate increased phos-
phorylation of the anabolic signaling molecule p70S6K, indicating a
dose-response relationship in an acute setting.42 As this relationship
does not appear to translate to a chronic setting, this suggests that the
mechanisms of this anabolic effect require further investigation.
An alternative view suggests that older adults actually require
more protein than their younger counterparts to protect against sar-
copenia. Contrary to the current RDA of 0.8e1.2 g$kg1$day1, a recent
evidence-based recommendation suggests an intake of
1.0e1.2 g$kg1$day1 would be more advisable.43 If the ﬁndings of
this review are considered from this perspective, most included
studies were above the lower limit of this recommendation, and so the
idea that baseline intakes were sufﬁcient to maximally stimulate MPS
would still apply. However, baseline intakes in 2 studies, while
meeting the RDA, were at or below the alternative
Table 4
Summary of Outcome Measures and Signiﬁcant Results
Author, Year Outcome Measures Signiﬁcant Protein Effect
Fiatarone et al, 199421 Muscle strength 1-RM leg strength (sum of L/R knee and hip extensors) NS*
Muscle size Thigh muscle CSA
Functional ability Self-paced gait velocity
Godard et al 2002,22 Muscle strength Knee extensor isometric and isokinetic MVC; 1-RM bilateral knee extension NS
Muscle size Right thigh whole muscle CSA
Bunout et al, 200423 Muscle strength L/R bicep isometric strength; L/R knee extensor isometric strength; L/R handgrip
strength
RH grip strength (P ¼ .031)
Muscle size Midarm, hip, and calf circumference
Functional ability 12-minute walk capacity
Body composition FFM; FM
Rosendahl et al, 200624,y Muscle strength 1-RM leg press NS
Functional ability Balance test; self-paced and maximum gait velocity; chair-stand test
Verdijk et al, 200925 Muscle strength 1-RM leg press; 1-RM leg extension NS
Muscle size Quadriceps muscle CSA
Body composition LBM; FM; % FM; leg LTM; leg % FM
Zak et al, 200926 Muscle strength L/R 1-RM knee extension; L/R 1-RM knee ﬂexion; L/R 1-RM hip extension; L/R 1-RM
hip knee ﬂexion
NS
Functional ability 6-minute walk capacity; POMA
Carlsson et al, 201127,y Body composition MM (intra cellular water proxy) NS
Kim et al, 201228 Muscle strength Knee extension Knee extension strength
(P ¼ .01)Functional ability Self-paced and maximum gait velocity
Body composition Total MM; appendicular MM; leg MM
Tieland et al, 201229 Muscle strength 1-RM leg press; 1-RM leg extension; handgrip strength LBM (P ¼ .006);
appendicular LTM
(P < .001); FM (P ¼ .001)
Functional ability SPPB
Body composition LBM; FM; appendicular LTM
Arnarson et al, 201330 Muscle strength Knee extensor isometric MVC NS
Functional ability Timed up-and-go; 6-minute walk capacity
Body composition LBM; appendicular LTM
Chalé et al, 201331 Muscle strength 1-RM leg press; L/R 1-RM knee extension NS
Muscle size Total muscle CSA of nondominant thigh
Functional ability SPPB; stair climb speed; 10 chair rise time; gait velocity
Body composition LBM; FM
Leenders et al, 201332 Muscle strength 1-RM leg press; 1-RM leg extension; handgrip strength NS
Muscle size Quadriceps muscle CSA
Functional ability 5x chair rise time
Body composition LBM; FM; % FM; leg LTM; leg FM
Daly et al, 201433 Muscle strength 1-RM leg extension Leg extension strength
(P ¼ .010);
LBM (P ¼ .007);
leg LTM (P < .05)
Muscle size Femur muscle CSA
Functional ability 4-square step test; timed up-and-go; 30-second chair rise test
Body composition Total body FM; body fat percentage; LBM; arm LTM, leg LTM
Franzke et al, 201534 Muscle strength Handgrip strength NS
Functional ability 6-minute walk capacity; 30-second chair rise test
Mitchell et al, 201535 Muscle strength 1-RM leg press; 1-RM leg extension; 1-RM chest press; Knee extension isometric
MVC
NS
Trabal et al, 201536 Muscle strength Leg ﬂexion overcoming isometric strength Leg ﬂexion (P ¼ .056)
Muscle size Mid upper arm muscle area; triceps skinfold; calf circumference
Functional ability Balance test; TUG; 5 chair rise time; 4m walk time
1-RM, 1-repetition maximum; CSA, cross-sectional area; L/R, right and left; MVC, maximum voluntary contraction; RH, right hand; POMA, Performance Oriented Mobility
Assessment; SPPB, Short Physical Performance Battery.
*NS indicates no signiﬁcant differences between the RET and protein supplement and RET only groups. For signiﬁcant results, the outcome measure and P value, where
available, are reported.
yRosendahl et al 200624 and Carlsson et al 201127 report results from the same study, presented separately as report different outcome measures.
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saw the greatest increase in protein intake relative to baseline. One of
these studies also fell into the small number, which found a signiﬁcant
difference in LBM between supplemented and control groups,29 and
the other reported a signiﬁcant difference in leg press peak power.31
Although not included as an outcome of the review, muscle power
is highly relevant in this context, as it is dependent upon muscle mass
and also declines with aging, impacting upon functional ability.44,45
This suggests that, under circumstances of lower baseline protein
intake, there may be potential for an additive effect of RET and protein
supplementation. This is of particular relevance to older adults who
are frail or in institutionalized care, as protein intakes for these groups
have been found to be lower than community-dwelling older people,
at 1.0 and 0.8 g$kg1$day1, respectively.46
In addition to the total daily protein intake, we may also consider
the inﬂuence of protein supplementationwith respect to the size of anindividual dose of supplement. Acute studies have demonstrated that
older adults require a bolus of at least 20 g of whey protein after
resistance exercise to stimulate the MPS level above that of an exer-
cised, unfed state,47 and that an even greater dose of 40 g is required
when using a different protein source.48 The studies included in this
review used a range of protein doses, some of which were at or above
thresholds previously found to be effective in an acute setting to in-
crease MPS. However, there were no consistent differences between
the results of these studies compared with those using lower protein
doses. Again, acute effects do not appear to translate to a chronic
response. This also has implications for total protein intake recom-
mendations for older adults conducting regular exercise, which are
partially based on this acute evidence. It is recommended that older
adults in this category require more protein than their inactive
counterparts, and that they should consume at least 1.2 g$kg1$day1
including a 20 g supplement after exercise.43 However, the results
D.K. Thomas et al. / JAMDA 17 (2016) 959.e1e959.e9959.e8from this review indicate that, from the perspective of improvements
in muscle mass and function, there may not necessarily be any beneﬁt
from the increased protein intake.
The efﬁcacy of protein supplementation in addition to RET has
been addressed by previous systematic reviews, with contrasting re-
sults. Cermak et al11 found in favor of an additive effect in terms of FFM
and muscle strength, concluding that protein/EAA supplementation
augmented responsiveness to RET in both older and younger partici-
pants, a discrepancy most likely attributable to the different criteria
used to deﬁne older populations. A mean age of at least 70 years was
required for studies to be included in our review, giving an overall
mean age of 77.4 years and a range of participant ages between 60 and
100 years, whereas the older cohort included in the previous review
was aged between 48 and 72 years. The previous review was also
restricted to only healthy participants, whereas we also included
participants deﬁned as frail or sarcopenic, and in fact only 1 study was
common to both reviews.25 More recently, Finger et al15 considered
the effects of RET and protein supplementation in older adults in
terms of FFM, and muscle mass and strength. Again, the lower age
limit was less than that of the current review at 60 years of age, and
included studies with participants as young as 50 years of age. Of the 9
included studies, 5 were also included our review, with the remaining
4 excluded at either the abstract or full text screening stages due to the
age criterion. Meta-analysis indicated a signiﬁcant effect on FFM,
which may again be a result of inclusion of younger participants. The
meta-analysis is an area in which the methodology differed from the
current review; previously, all studies with comparable outcomes
were included in meta-analyses, however, in this review, we reviewed
the similarity of study protocols based on a number of characteristics
prior to meta-analysis, which indicated that very few of the studies
were truly comparable. Further methodologic differences also allowed
the current review to provide a more comprehensive view of the
subject matter; a more extensive list of outcome measures includes
measures of functional ability, which are highly relevant when
considering the practical effects of an intervention, as well as a greater
range of body composition outcomes. Furthermore, the eligibility
criteria for the current review were less restrictive, as we did not
exclude on the basis of other macronutrients in the supplement,
allowing a greater number of studies to be included.
In general, the overall quality of the included studies wasmoderate
to high, although several studies scored poorly for internal validity. In
particular, approximately one-half of studies did not report blinding of
all participants, and 4 failed to use any placebo in the control groups,
meaning these studies may have been susceptible to performance
bias.
Limitations
The greatest limitation of this review is the lack of meta-analysis
data. Outcome measures showed a high degree of heterogeneity and
data were not presented uniformly, and methodologic diversity was
high, with variation in protein/EAA supplementation, training pro-
tocols, and duration of intervention. As a result, comparable outcome
measures were limited, and differences in methodology meant that
comparisons betweenmost studies would not have been valid. Ideally,
subgroup analysis would have been completed, for example for frail/
sarcopenic and healthy groups, and for different distributions and
timings of protein intake as the number of doses and proximity to
exercise may have affected the response, but methodologic differ-
ences did not allow this. However, the vast majority of results indicate
no additional effect of protein supplementation, and this did not
appear to differ according to population or protocol characteristics,
other than that of baseline protein intake discussed above.
The reviewmay also be limited by the sample sizes of the included
studies, some of which were relatively low and, therefore, may havelacked sufﬁcient power to identify small differences between groups.
Eight of the studies24,26,28e33 reported a power calculation that
deemed the sample size to be adequate, and therewas no difference in
terms of signiﬁcant results between these and the studies that did not
report a power calculation. However, the majority of these were
powered for only selected outcome measures, usually body compo-
sition, meaning the sample sizes may not have been sufﬁcient for
other outcome measures; this is particularly important to consider
with respect to more complex outcomes, such as measures of func-
tional ability, which may require larger sample sizes to detect signif-
icant differences.
Conclusions
Protein/EAA supplementation does not signiﬁcantly augment the
effects of progressive RET in older adults in terms of muscle strength,
muscle size, body composition, or functional ability. The review does,
however, support the prescription of RET regimens to maintain and
increase muscle mass and strength in older populations, which may
help to combat sarcopenia and frailty.
The ﬁndings also suggest that there may be an additional beneﬁt of
protein supplementation and RET programs in frail older adults who
do not regularly consume sufﬁcient protein, particularly those in
institutionalized care. Thus, future research may consider exploring
this by conducting trials placing greater emphasis on the baseline
protein intake of participants. Likewise, little discussion has been
given here to the protein supplement characteristics, such as the
amount, timing, and distribution of ingestion, and further research
may investigate these areas to fully determine whether protein sup-
plementation could be protective against sarcopenia.
Supplementary Data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jamda.2016.07.002.
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